WHO. WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/. Accessed 4 Aug 2021.
Horby P, Lim WS, Emberson JR, et al.. Dexamethasone in hospitalized patients with Covid-19 - Preliminary report. N Engl J Med. 2020.
W. H. O. Rapid Evidence Appraisal for COVID-19 Therapies Working Group. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA; 2020.
Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008–12.
Article
CAS
PubMed
Google Scholar
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339(7716):b2535.
Article
PubMed
PubMed Central
Google Scholar
Cogliati-Dezza F, Oliva A, Cancelli F, et al. Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection. Diagn Microbiol Infect Dis. 2021;100(2):115347.
Article
CAS
PubMed
PubMed Central
Google Scholar
Feng ZC, Li J, Yao SH, et al. Clinical factors associated with progression and prolonged viral shedding in COVID-19 patients: a multicenter study. Aging Dis. 2020;11(5):1069–81.
Article
PubMed
PubMed Central
Google Scholar
Yan D, Liu XY, Zhu YN, et al. Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection. Eur Resp J. 2020;56(1):2000799.
Article
CAS
Google Scholar
Yuan ML, Xu XX, Xia DP, et al. Effects of corticosteroid treatment for non-severe COVID-19 pneumonia: a propensity score-based analysis. Shock. 2020;54(5):638–43.
Article
CAS
PubMed
Google Scholar
Chen XD, Zhu BY, Hong WX, et al. Associations of clinical characteristics and treatment regimens with viral RNA shedding duration in patients with COVID-19. Int J Infect Dis. 2020;98:252–60.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hu ZG, Li SJ, Yang AL, et al. Delayed hospital admission and high-dose corticosteroids potentially prolong SARS-CoV-2 RNA detection duration of patients with COVID-19. Eur J Clin Microbiol Infect Dis. 2021;40(4):841–8.
Article
CAS
PubMed
Google Scholar
Huang R, Zhu CW, Wang J, et al. Corticosteroid therapy is associated with the delay of SARS-CoV-2 clearance in COVID-19 patients. Eur J Pharmacol. 2020;889:173556.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li Q, Li WX, Jin YP, et al. Efficacy evaluation of early, low-dose, short-term corticosteroids in adults hospitalized with non-severe COVID-19 pneumonia: a retrospective cohort study. Infect Dis Therapy. 2020;9:823.
Article
Google Scholar
Wells G, Shea B, O’Connell D, et al.. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. Accessed 3 April 2020.
IntHout J, Ioannidis JPA, Rovers MM, Goeman JJ. Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open. 2016;6(7):e010247.
Article
PubMed
PubMed Central
Google Scholar
Spruance SL, Reid JE, Grace M, Samore M. Hazard ratio in clinical trials. Antimicrob Agents Chemother. 2004;48(8):2787–92.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang J, Yu KF. What’s the relative risk? a method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690–1.
Article
CAS
PubMed
Google Scholar
National Health Commission. Chinese clinical guidance for COVID-19 pneumonia diagnosis and treatment (7th edition). http://kjfymeetingchina.org/msite/news/show/cn/3337.htm. Accessed 15 May 2020.
Peng FJ, Tu L, Yang YS, et al. Management and treatment of COVID-19: the Chinese experience. Can J Cardiol. 2020;36(6):915–30.
Article
PubMed
Google Scholar
Viechtbauer W, Cheung MW. Outlier and influence diagnostics for meta-analysis. Res Synth Meth. 2010;1(2):112–25.
Article
Google Scholar
Cao HR, Zhu XY, Zhou L, et al. Factors associated with delayed viral shedding in COVID-19 infected patients: a retrospective small-scale study. Resp Med. 2021;178:106328.
Article
Google Scholar
Chang D, Zhao P, Zhang DW, et al. Persistent viral presence determines the clinical course of the disease in COVID-19. J Allergy Clin Immunol Pract. 2020;8(8):2585.
Article
PubMed
PubMed Central
Google Scholar
Chen Q, Song Y, Wang L, et al. Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study. Expert Rev Resp Med. 2020.
Chen YF, Li LJ. Influence of corticosteroid dose on viral shedding duration in patients with COVID-19. Clin Infect Dis. 2021;72(7):1298–1300.
Article
CAS
PubMed
Google Scholar
Ding C, Feng XW, Chen YF, et al. Effect of corticosteroid therapy on the duration of SARS-CoV-2 clearance in patients with mild COVID-19: a retrospective cohort study. Infect Dis Therapy. 2020;9(4):943–52.
Article
Google Scholar
Fang XW, Mei Q, Yang TJ, et al. Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19. J Infect. 2020;81(1):147–9.
PubMed
PubMed Central
Google Scholar
Fu HY, Luo Y, Gao JP, et al. Effects of short-term low-dose glucocorticoids for patients with mild COVID-19. BioMed Res Int. 2020:2854186.
Gong Y, Guan L, Jin Z, Chen SX, Xiang GM, Gao BA. Effects of methylprednisolone use on viral genomic nucleic acid negative conversion and CT imaging lesion absorption in COVID-19 patients under 50 years old. J Med Virol. 2020;92(11):2551–5.
Article
CAS
PubMed
Google Scholar
Hu FY, Yin G, Chen YP, et al. Corticosteroid, oseltamivir, and delayed admission are independent risk factors for prolonged viral shedding in patients with coronavirus disease 2019. Clin Resp J. 2020;14(11):1067–75.
Article
CAS
Google Scholar
Jeronimo CMP, Farias MEL, Val FFA, et al. Methylprednisolone as adjunctive therapy for patients hospitalized with COVID-19 (Metcovid): a randomised, double-blind, phase IIb, placebo-controlled trial. Clin Infect Dis. 2020;72(9):e373–81.
Article
CAS
Google Scholar
Ji JJ, Zhang JX, Shao ZY, Xie QF, Zhong L, Liu ZF. Glucocorticoid therapy does not delay viral clearance in COVID-19 patients. Crit Care. 2020;24(1):565.
Article
PubMed
PubMed Central
Google Scholar
Li TZ, Cao ZH, Chen Y, et al. Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19. J Med Virol. 2020;93:506.
Article
PubMed
CAS
Google Scholar
Li YM, Meng QH, Rao X, et al. Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study. Crit Care. 2020;24(1):698–707.
Article
PubMed
PubMed Central
Google Scholar
Liang MY, Chen P, He M, et al. Corticosteroids treatment of patients with coronavirus disease 2019: a propensity score matching study. Curr Med Sci. 2021;41(1):24–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu J, Zhang S, Dong X, et al. Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome. J Clin Investig. 2020;130(12):6417–28.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu ZB, Li X, Fan GH, et al. Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19. Clin Microbiol Infect. 2020;27(1):112–7.
Article
PubMed
PubMed Central
CAS
Google Scholar
Lu YY, Liu F, Tong GL, et al. Clinical evidence of an interferon-glucocorticoid therapeutic synergy in COVID-19. Signal Transduct Target Ther. 2021;6(1):107–17.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ma Q, Qi D, Deng XY, et al. Corticosteroid therapy for patients with severe novel coronavirus disease 2019. Eur Rev Med Pharmacol Sci. 2020;24(15):8194–201.
CAS
PubMed
Google Scholar
Ma YM, Zeng HH, Zhan ZJ, et al. Corticosteroid use in the treatment of COVID-19: a multicenter retrospective study in Hunan, China. Front Pharmacol. 2020;11:1198.
Article
CAS
PubMed
PubMed Central
Google Scholar
Masia M, Fernandez-Gonzalez M, Garcia JA, Padilla S, Gutierrez F. Lack of detrimental effect of corticosteroids on antibody responses to SARS-CoV-2 and viral clearance in patients hospitalized with COVID-19. J Infect. 2020;82(3):414–51.
Article
PubMed
PubMed Central
CAS
Google Scholar
Ni Q, Ding C, Li YT, et al. Effect of low-to-moderate dose glucocorticoids on viral clearance in COVID-19: a retrospective study. Chin J Clin Infect Dis. 2020;13(1):21–4.
Google Scholar
Qi L, Yang Y, Jiang DX, et al. Factors associated with the duration of viral shedding in adults with COVID-19 outside of Wuhan, China: a retrospective cohort study. Int J Infect Dis. 2020;96:531–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shi D, Wu WR, Wang Q, et al. Clinical characteristics and factors associated with long-term viral excretion in patients with SARS-CoV-2 infection: a single center 28-day study. J Infect Dis. 2020;222(6):910–8.
Shu HM, He S, Sun Y, et al. Factors influencing viral clearance in mild COVID-19 and clinical characteristics of asymptomatic patients. Biomed Res Int. 2021;2021:5909612.
Article
PubMed
PubMed Central
CAS
Google Scholar
Spagnuolo V, Guffanti M, Galli L, et al. Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19. Sci Rep. 2020;10(1):21291.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wu CM, Hou DN, Du CL, et al. Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis. Crit Care. 2020;24(1):643.
Article
PubMed
PubMed Central
Google Scholar
Xia Q, Xu KJ, Ni Q, et al. Clinical efficacy of methylprednisolone and the combined use of lopinavir/ritonavir with arbidol in treatment of coronavirus disease 2019. J Med Virol. 2021;93(7):4446–53.
Article
CAS
PubMed
Google Scholar
Xu KJ, Chen YF, Yuan J, et al. Factors associated with prolonged viral RNA shedding in patients with COVID-19. Clin Infect Dis. 2020;71(15):799-806.
Article
CAS
PubMed
Google Scholar
Zha L, Li SR, Pan LL, et al. Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19). Med J Aust. 2020;212(9):416–20.
Article
PubMed
PubMed Central
Google Scholar
Zuo Y, Liu YL, Zhong Q, Zhang K, Xu YH, Wang ZX. Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: a retrospective study in two designated hospitals in Anhui, China. J Med Virol. 2020;92(11):2666–74.
Article
CAS
PubMed
Google Scholar
Xiong LQ, Jin W, Hu XM, et al. Effect of glucocorticoid therapy on the prognosis of patients with severe and critical COVID-19: a single-center retrospective cohort study. Eur Rev Med Pharmacol Sci. 2021;25(2):1070–9.
PubMed
Google Scholar
Yousefifard M, Mohamed Ali K, Aghaei A, et al. Corticosteroids on the management of coronavirus disease 2019 (COVID-19): a systemic review and meta-Analysis. Iran J Public Health. 2020;49(8):1411–21.
PubMed
PubMed Central
Google Scholar
Arabi YM, Mandourah Y, Al-Hameed F, et al. Corticosteroid therapy for critically ill patients with middle east respiratory syndrome. Am J Respir Crit Care Med. 2018;197(6):757–67.
Article
PubMed
Google Scholar
Cao B, Gao H, Zhou B, et al. Adjuvant corticosteroid treatment in adults with influenza A (H7N9) viral pneumonia. Crit Care Med. 2016;44(6):e318–28.
Article
CAS
PubMed
Google Scholar
Lee N, Chan K, Hui DS, et al. Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients. J Clin Virol. 2004;31(4):304–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ryoo SM, Kim WY, Sohn CH, et al. Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days. Influenza Other Respir Viruses. 2013;7(5):833–7.
Article
CAS
PubMed
Google Scholar
Butler WT, Rossen RD. Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone. J Clin Invest. 1973;52(10):2629–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Van Mens SP, Meijvis SC, Grutters JC, Vlaminckx BJ, Bos WJ, Rijkers GT. Dexamethasone treatment has no effect on the formation of pneumococcal antibodies during community-acquired pneumonia. Clin Vaccine Immunol. 2012;19(5):811–3.
Article
PubMed
PubMed Central
CAS
Google Scholar
Di Castelnuovo A, Costanzo S, Antinori A, et al. Heparin in COVID-19 patients is associated with reduced in-hospital mortality: the multicenter italian CORIST study. Thromb Haemost. 2021;121(8):1054–65.
Article
PubMed
Google Scholar
Li J, Liao X, Zhou Y, et al. Comparison of associations between glucocorticoids treatment and mortality in COVID-19 patients and SARS patients: a systematic review and meta-analysis. Shock. 2021;56(2):215–28.
Article
CAS
PubMed
Google Scholar
Mondi A, Lorenzini P, Castilletti C, et al. Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital. Int J Infect Dis. 2021;105:532–9.
Article
CAS
PubMed
PubMed Central
Google Scholar